<?xml version="1.0" encoding="UTF-8"?>
<p id="par0625">Triggering large-scale manufacturing and planning of vaccine or therapeutic priorities. As soon as a vaccine or therapy shows promise in key clinical trials (i.e., it has been proven to be safe and also appears to be effective), government should work with industry to begin planning for mass manufacturing, distribution and administration even before approvals, to ensure that there will be a sufficient supply for mass distribution and obtain a final regulatory approval by ensuring that the manufacture of other vaccines (seasonal influenza vaccine, mandatory infant vaccines) will not be affected.</p>
